We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
The epidemiology, symptoms, diagnosis and management of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2).
An overview of the NHS diabetic eye screening (DES) programme, its services and contact information.
Find out which drinks are liable for the Soft Drinks Industry Levy, and how much you may need to pay.
BBVU offers laboratory reference services and carries out research and development on hepatitis viruses, and has a remit for blood safety.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
The new presentation of Mounjaro gives four doses for once-a-week treatment over a month.
Guidance to hospital blood banks (HBBs) on flexible approaches to requirements
Falsified, potentially harmful Ozempic▼ and Saxenda products have been found in the UK.
Device-specific guidance for manufacturers on reporting adverse incidents under the vigilance system
Information about ensuring blood and blood component safety.
You can claim relief to pay no Customs Duty and VAT if you're importing therapeutic substances of human origin, blood-grouping or tissue-typing reagents, or related packaging, solvents and accessories.
Guidance and additional resources about the 'opt-out' testing policy for blood-borne viruses in prisons and other secure settings.
What blood establishments, blood banks and manufacturers of blood products need to do to ensure the safety and quality of blood and blood products.
This trial was conducted during routine outpatient department hours in a primary health care setting in Puducherry, India
Information on depleted uranium (DU) including what it is, its uses, health effects and protection from exposure.
These documents explain how OHID is approaching reduction and food and drink reformulation as part of the government’s obesity strategy.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).